Email Us
View Reports

Cholic acid Market

Cholic Acid Market Analysis - By Region (Europe, Asia-Pacific, Americas and the Middle East & Africa) - Industry Size, Share, Trends and Growth Forecast to 2024

  • ID : 219748105  |  
  • Published : Jul-2019  |  
  • Region : Global  |  
  • Pages : 140   |  
  • Publisher : Market Research Future

The Global Cholic Acid Market is expected to register a CAGR of 7.90% to reach USD 92,412.51 Thousand till 2024. Cholic acid is a primary bile acid synthesized by the liver from cholesterol. The role of bile acids is to emulsify (breakdown into small particles) fats and thus promote the process of digestion. Cholic acid is primarily used as an intermediate for the production of ursodeoxycholic acid (UDCA), which is an active pharmaceutical ingredient (API) used for various indications like the dissolution of gall stones and treating and preventing liver diseases.

The high prevalence of gallbladder cancer, high prevalence of obesity, and increasing geriatric population are expected to enhance the market growth. However, stringent regulatory policies are projected to curb the growth of the market.

Market Dynamics

Cholic acid has been gaining significance in recent years owing to the high prevalence of gallbladder cancer. According to the American Cancer Society, gallstones are one of the major factors contributing to gallbladder cancer. The cases of gallbladder cancer diagnosed are increasing globally. For instance, according to a study by the World Cancer Research Fund (WCRF) International, around 2,20,000 new cases of gallbladder cancer were diagnosed globally in the year 2018. This increase in the cases of gallbladder cancer reflects the probable increase in the increased prevalence of one of its factors, bile stones. Thus, the growing prevalence of gallbladder cancer globally has led to an increased usage of cholic acid, which thereby provides a favorable scenario for the market to grow during the forecast period.

Key Players

The prominent players in the global cholic acid market are Alchem International Ltd (US), Daewoong Bio, Inc. (South Korea),Dipharma Francis SRL (Italy), Erregierre SpA (Italy), Fujimoto Chemicals (Japan), Industria Chimica Emiliana SRL (Italy), Istituto Biologico Chemioterapico SpA (Italy), Kinsy SL (Spain), New Zealand Pharmaceuticals Limited (New Zealand), Panjin Hengchanglong Pharmaceutical (China), PharmaZell GmbH (Germany), Retrophin, Inc. (US), Showa Denko KK (Japan), Suzhou Tianlu Biopharmaceuticals Co. Ltd (China), and Zhejiang Yongning Pharmaceutical (Zhejiang).

Regional Analysis

The global cholic acid market, based on region, is divided into Europe, Asia-Pacific, Americas, and Middle East & Africa.

Europe is expected to hold the largest share, with 39.5% of the global cholic acid market. This is due to the presence of major manufacturers like Industria Chimica Emiliana (ICE), Istituto Biologico Chemioterapico SpA, Prodotti Chimici Alimentari (PCA) SpA; and high production of cholic acid.

Asia-Pacific consists of China, Japan, South Korea, India, and others. Owing to a high number of obese individuals, which is one of the risk factors for gallstones, the Asia-Pacific accounts for the second-largest market share in the global cholic acid market and is expected to rise during the forecast period.

The Americas is expected to grow at the fastest growth rate, with 8.47% CAGR during the forecast period. The Americas consist of two main regions—North America and Latin America. The North America market is further bifurcated into the US and Canada. Increase in the prevalence of gall bladder cancer in the region, which reflects the increase in gallstones, is expected to boost the growth of the Americas cholic acid market during the forecast period

Middle East & Africa accounts for the least market share in the global cholic acid market and due to the increase in the geriatric population, is expected to show steady growth during the forecast period.

The key strategy followed by players operating in the global cholic acid market is mergers & acquisitions.

  • In April 2018, Dipharma Francis SRL acquired Kalexsyn Inc., a contract research organization (CRO) that offers chemistry services to the biotechnology and pharmaceutical industries

  • In July 2016, Archer Capital acquired New Zealand Pharmaceuticals Limited, which enabled the enhancement of the company’s market share in the global cholic acid market.

  • In April 2016, PharmaZell GmbH acquired a majority stake in a new JV created from the bile business of Fayman International (Australia) to expand its geographic presence in this region.

Market Segmentation

Global Cholic acid Market, by Region

  • Europe

    • Western Europe

      • Italy
      • Germany
      • France
      • UK
      • Spain
      • Rest of Western Europe

    • Eastern Europe

  • Asia-Pacific

    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific

  • Americas

    • North America
    • US
    • Canada
    • Latin America

  • Middle East & Africa

    • Middle East
    • Africa

Available Additional Customizations

  • Company Profiles of Other Key Players
  • Cholic Acid Market, Industry Trends

Intended Audience

  • Pharmaceutical companies
  • Contract research manufacturing organizations
  • Research & development organizations

1. Market Definition

1.1  Definition            12

1.2  Scope Of The Study         12

1.3  Market Structure             12

2. Research Methodology

2.1  Research Process             13

2.2  Primary Research             14

2.3  Secondary Research       15

2.4  Market Size Estimation  16

2.5  Forecast Model 16

3. Market Dynamics

3.1  Overview            17

3.2  Drivers  18

3.2.1              High Prevalence Of Gallbladder Cancer   18

3.2.2              High Prevalence Of Obesity         18

3.2.3              Increasing Geriatric Population  18

3.2.4              Drivers Impact Analysis  19

3.3  Restraints            19

3.3.1              Stringent Regulatory Policies       19

3.3.2              Restraints Impact Analysis            19

3.4  Opportunities    20

3.4.1              Low Manufacturing In The Middle East & Africa  20

4. Market Factor Analysis

4.1  Value Chain Analysis       21

4.1.1              Overview            21

4.1.2              R&D       21

4.1.3              Procurement Of Raw Material    21

4.1.4              Manufacturing  21

4.1.5              Distribution & Sales        22

4.1.6              Post-Sales Monitoring    22

4.2  Porter’s Five Forces Model           23

4.2.1              Overview            23

4.2.2              Threat Of New Entrants 24

4.2.3              Bargaining Power Of Suppliers   24

4.2.4              Threat Of Substitutes     24

4.2.5              Bargaining Power Of Buyers        24

4.2.6              Intensity Of Rivalry          24

5. Global Cholic Acid Market, By Region

5.1 Introduction 25 

5.2 Europe 27 

5.2.1 Western Europe 28 

5.2.2 Eastern Europe 32 

5.3 Asia-Pacific 33 

5.3.1 China 34 

5.3.2 India 34 

5.3.3 Japan 35 

5.3.4 Australia 35 

5.3.5 South Korea 36 

5.3.6 Rest Of Asia-Pacific 36 

5.4 Americas 37 

5.4.1 North America 38 

5.4.2 Latin America 39 

5.5 Middle East & Africa 40 

5.5.1 Middle East 41 

5.5.2 Africa 41 

6. Competitive Landscape

6.1 Company Position Analysis 42 

7. Company Profiles

7.1 Alchem International Ltd 44 

7.1.1 Company Overview 44 

7.1.2 Financial Overview 44 

7.1.3 Products/Services Offered 44 

7.1.4 Key Developments 44 

7.1.5 SWOT Analysis 44 

7.1.6 Key Strategies 45 

7.2 Daewoong Bio, Inc. 46 

7.2.1 Company Overview 46 

7.2.2 Financial Overview 46 

7.2.3 Products/Services Offered 46 

7.2.4 Key Developments 46 

7.2.5 SWOT Analysis 46 

7.2.6 Key Strategies 47 

7.3 Dipharma Francis SRL 48 

7.3.1 Company Overview 48 

7.3.2 Financial Overview 48 

7.3.3 Products Offering 48 

7.3.4 Key Developments 48 

7.3.5 SWOT Analysis 48 

7.3.6 Key Strategies 49 

7.4 Erregierre SpA 50 

7.4.1 Company Overview 50 

7.4.2 Financial Overview 50 

7.4.3 Products/Services Offered 50 

7.4.4 Key Developments 50 

7.4.5 SWOT Analysis 50 

7.4.6 Key Strategies 50 

7.5 Fujimoto Chemicals 51 

7.5.1 Company Overview 51 

7.5.2 Financial Overview 51 

7.5.3 Products/Services Offered 51 

7.5.4 Key Developments 51 

7.5.5 SWOT Analysis 51 

7.5.6 Key Strategies 51 

7.6 Industria Chimica Emiliana SRL 52 

7.6.1 Company Overview 52 

7.6.2 Financial Overview 52 

7.6.3 Products/Services Offered 52 

7.6.4 Key Developments 52 

7.6.5 SWOT Analysis 52 

7.6.6 Key Strategies 53 

7.7 Istituto Biologico Chemioterapico SpA 54 

7.7.1 Company Overview 54 

7.7.2 Financial Overview 54 

7.7.3 Products/Services Offered 54 

7.7.4 Key Developments 54 

7.7.5 SWOT Analysis 54 

7.7.6 Key Strategies 54 

7.8 Kinsy SL 55 

7.8.1 Company Overview 55 

7.8.2 Financial Overview 55 

7.8.3 Products/Services Offered 55 

7.8.4 Key Developments 55 

7.8.5 SWOT Analysis 55 

7.8.6 Key Strategies 55 

7.9 New Zealand Pharmaceuticals Limited 56 

7.9.1 Company Overview 56 

7.9.2 Financial Overview 56 

7.9.3 Products/Services Offered 56 

7.9.4 Key Developments 56 

7.9.5 SWOT Analysis 57 

7.9.6 Key Strategies 57 

7.10 Panjin Hengchanglong Pharmaceutical 58 

7.10.1 Company Overview 58 

7.10.2 Financial Overview 58 

7.10.3 Products/Services Offered 58 

7.10.4 Key Developments 58 

7.10.5 SWOT Analysis 58 

7.10.6 Key Strategies 59 

7.11 PharmaZell GmbH 60 

7.11.1 Company Overview 60 

7.11.2 Financial Overview 60 

7.11.3 Products/Services Offered 60 

7.11.4 Key Developments 60 

7.11.5 SWOT Analysis 61 

7.11.6 Key Strategies 61 

7.12 Retrophin, Inc. 62 

7.12.1 Company Overview 62 

7.12.2 Financial Overview 62 

7.12.3 Products/Services Offered 63 

7.12.4 Key Developments 63 

7.12.5 SWOT Analysis 63 

7.12.6 Key Strategies 63 

7.13 Showa Denko KK 64 

7.13.1 Company Overview 64 

7.13.2 Financial Overview 64 

7.13.3 Products/Services Offered 65 

7.13.4 Key Developments 65 

7.13.5 SWOT Analysis 65 

7.13.6 Key Strategies 65 

7.14 Suzhou Tianlu Biopharmaceuticals Co. Ltd 66 

7.14.1 Company Overview 66 

7.14.2 Financial Overview 66 

7.14.3 Products/Services Offered 66 

7.14.4 Key Developments 66 

7.14.5 SWOT Analysis 66 

7.14.6 Key Strategies 67 

7.15 Zhejiang Yongning Pharmaceutical 68 

7.15.1 Company Overview 68 

7.15.2 Financial Overview 68 

7.15.3 Products/Services Offered 68 

7.15.4 Key Developments 68 

7.15.5 SWOT Analysis 68 

7.15.6 Key Strategies 69 

8. Appendix

8.1 References 70 

8.2 Related Reports 70 

TABLE 1 PRIMARY INTERVIEWS 16 

TABLE 2 GLOBAL HEMP BASED PRODUCTS MARKET, BY REGION 2015-2023 (USD MILLION) 32 

TABLE 3 AMERICAS HEMP BASED PRODUCTS MARKET, BY REGION 2015-2023 (USD MILLION) 33 

TABLE 4 NORTH AMERICA HEMP BASED PRODUCTS MARKET, BY REGION 2015-2023 (USD MILLION) 33 

TABLE 5 EUROPE HEMP BASED PRODUCTS MARKET, BY REGION 2015-2023 (USD MILLION) 34 

TABLE 6 WESTERN EUROPE HEMP BASED PRODUCTS MARKET, BY REGION 2015-2023 (USD MILLION) 34 

TABLE 7 ASIA-PACIFIC: HEMP BASED PRODUCTS MARKET, BY COUNTRY 2015–2023 (USD MILLION) 35 

TABLE 8 REST OF THE WORLD (ROW) HEMP BASED PRODUCTS MARKET, BY REGION 2015-2023 (USD MILLION) 35 

TABLE 9 GLOBAL HEMP BASED PRODUCTS MARKET , BY INDUSTRIAL APPLICATION, 2015–2023 (USD MILLION) 36 

TABLE 10 GLOBAL HEMP BASED PRODUCTS MARKET, FOR HEMP CBD BY TYPE, 2015–2023 (USD MILLION) 37 

TABLE 11 GLOBAL HEMP BASED PRODUCTS MARKET, FOR HEMP CBD BY TYPE, 2015–2028 (VOLUME) 38 

TABLE 12 GLOBAL HEMP BASED PRODUCTS MARKET, FOR HEMP CBD BY TYPE, 2019–2023 (VOLUME) 38 

TABLE 13 GLOBAL CBD OIL MARKET, BY PRODUCT, 2015–2023 (USD MILLION) 40 

TABLE 14 GLOBAL CBD OIL MARKET, FOR MARIJUANA-DERIVED CBD OIL BY REGION, 2015–2023 (USD MILLION) 41 

TABLE 15 GLOBAL CBD OIL MARKET, FOR HEMP-DERIVED CBD OIL BY REGION, 2015–2023 (USD MILLION) 42 

TABLE 16 GLOBAL CBD OIL MARKET, BY APPLICATION, 2015–2023 (USD MILLION) 44 

TABLE 17 GLOBAL CBD OIL MARKET, FOR PAIN RELIEF BY REGION, 2015–2023 (USD MILLION) 45 

TABLE 18 GLOBAL CBD OIL MARKET, FOR NEUROLOGICAL DISORDERS BY REGION, 2015–2023 (USD MILLION) 46 

TABLE 19 GLOBAL CBD OIL MARKET, FOR FIBROMYALGIA BY REGION, 2015–2023 (USD MILLION) 46 

TABLE 20 GLOBAL CBD OIL MARKET, FOR MOOD DISORDERS BY REGION, 2015–2023 (USD MILLION) 47 

TABLE 21 GLOBAL CBD OIL MARKET, FOR DIABETES BY REGION, 2015–2023 (USD MILLION) 47 

TABLE 22 GLOBAL CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2015–2023 (USD MILLION) 49 

TABLE 23 GLOBAL CBD OIL MARKET, FOR E-COMMERCE WEBSITES BY REGION 2015–2023 (USD MILLION) 50 

TABLE 24 GLOBAL CBD OIL MARKET, FOR RETAIL PHARMACIES BY REGION 2015–2023 (USD MILLION) 50 

TABLE 25 GLOBAL CBD OIL MARKET, FOR MEDICAL MARIJUANA DISPENSARIES BY REGION 2015–2023 (USD MILLION 51 

TABLE 26 GLOBAL CBD OIL MARKET, FOR HOSPITAL PHARMACIES BY REGION 2015–2023 (USD MILLION 51 

TABLE 27 GLOBAL CBD OIL MARKET, BY REGION 2015–2023 (USD MILLION) 54 

TABLE 28 AMERICAS: CBD OIL MARKET, BY REGION 2015–2023 (USD MILLION) 55 

TABLE 29 AMERICAS: CBD OIL MARKET, BY PRODUCT 2015–2023 (USD MILLION) 55 

TABLE 30 AMERICAS: CBD OIL MARKET, BY APPLICATION 2015–2023 (USD MILLION) 56 

TABLE 31 AMERICAS: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2015–2023 (USD MILLION) 56 

TABLE 32 NORTH AMERICA: CBD OIL MARKET, BY COUNTRY 2015–2023 (USD MILLION) 57 

TABLE 33 NORTH AMERICA: CBD OIL MARKET, BY PRODUCT 2015–2023 (USD MILLION) 57 

TABLE 34 NORTH AMERICA: CBD OIL MARKET, BY APPLICATION 2015–2023 (USD MILLION) 58 

TABLE 35 NORTH AMERICA: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2015–2023 (USD MILLION) 58 

TABLE 36 US: CBD OIL MARKET, BY PRODUCT 2015–2023 (USD MILLION) 59 

TABLE 37 US: CBD OIL MARKET, BY APPLICATION 2015–2023 (USD MILLION) 59 

TABLE 38 US: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2015–2023 (USD MILLION) 60 

TABLE 39 CANADA: CBD OIL MARKET, BY PRODUCT 2015–2023 (USD MILLION) 60 

TABLE 40 CANADA: CBD OIL MARKET, BY APPLICATION 2015–2023 (USD MILLION) 61 

TABLE 41 CANADA: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2015–2023 (USD MILLION) 61 

TABLE 42 SOUTH AMERICA: CBD OIL MARKET, BY PRODUCT 2015–2023 (USD MILLION) 62 

TABLE 43 SOUTH AMERICA: CBD OIL MARKET, BY APPLICATION 2015–2023 (USD MILLION) 62 

TABLE 44 SOUTH AMERICA: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2015–2023 (USD MILLION) 63 

TABLE 45 EUROPE: CBD OIL MARKET, BY REGION 2015–2023 (USD MILLION) 64 

TABLE 46 EUROPE: CBD OIL MARKET, BY PRODUCT 2015–2023 (USD MILLION) 64 

TABLE 47 EUROPE: CBD OIL MARKET, BY APPLICATION 2015–2023 (USD MILLION) 65 

TABLE 48 EUROPE: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2015–2023 (USD MILLION) 65 

TABLE 49 WESTERN EUROPE: CBD OIL MARKET, BY COUNTRY 2015–2023 (USD MILLION) 66 

TABLE 50 WESTERN EUROPE: CBD OIL MARKET, BY PRODUCT 2015–2023 (USD MILLION) 67 

TABLE 51 WESTERN EUROPE CBD OIL MARKET, BY APPLICATION 2015–2023 (USD MILLION) 67 

TABLE 52 WESTERN EUROPE: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2015–2023 (USD MILLION) 68 

TABLE 53 GERMANY: CBD OIL MARKET, BY PRODUCT 2015–2023 (USD MILLION) 69 

TABLE 54 GERMANY: CBD OIL MARKET, BY APPLICATION 2015–2023 (USD MILLION) 69 

TABLE 55 GERMANY: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2015–2023 (USD MILLION) 70 

TABLE 56 UK: CBD OIL MARKET, BY PRODUCT 2015–2023 (USD MILLION) 70 

TABLE 57 UK: CBD OIL MARKET, BY APPLICATION 2015–2023 (USD MILLION) 71 

TABLE 58 UK: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2015–2023 (USD MILLION) 71 

TABLE 59 FRANCE: CBD OIL MARKET, BY PRODUCT 2015–2023 (USD MILLION) 72 

TABLE 60 FRANCE: CBD OIL MARKET, BY APPLICATION 2015–2023 (USD MILLION) 72 

TABLE 61 FRANCE: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2015–2023 (USD MILLION) 73 

TABLE 62 SPAIN: CBD OIL MARKET, BY PRODUCT 2015–2023 (USD MILLION) 73 

TABLE 63 SPAIN: CBD OIL MARKET, BY APPLICATION 2015–2023 (USD MILLION) 74 

TABLE 64 SPAIN: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2015–2023 (USD MILLION) 74 

TABLE 65 ITALY: CBD OIL MARKET, BY PRODUCT 2015–2023 (USD MILLION) 75 

TABLE 66 ITALY: CBD OIL MARKET, BY APPLICATION 2015–2023 (USD MILLION) 75 

TABLE 67 ITALY: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2015–2023 (USD MILLION) 76 

TABLE 68 REST OF WESTERN EUROPE: CBD OIL MARKET, BY PRODUCT 2015–2023 (USD MILLION) 76 

TABLE 69 REST OF WESTERN EUROPE: CBD OIL MARKET, BY APPLICATION 2015–2023 (USD MILLION) 77 

TABLE 70 REST OF WESTERN EUROPE: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2015–2023 (USD MILLION) 77 

TABLE 71 EASTERN EUROPE: CBD OIL MARKET, BY PRODUCT 2015–2023 (USD MILLION) 78 

TABLE 72 EASTERN EUROPE: CBD OIL MARKET, BY APPLICATION 2015–2023 (USD MILLION) 78 

TABLE 73 EASTERN EUROPE: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2015–2023 (USD MILLION) 79 

TABLE 74 ASIA-PACIFIC: CBD OIL MARKET, BY COUNTRY 2015–2023 (USD MILLION) 80 

TABLE 75 ASIA-PACIFIC: CBD OIL MARKET, BY PRODUCT 2015–2023 (USD MILLION) 81 

TABLE 76 ASIA-PACIFIC: CBD OIL MARKET, BY APPLICATION 2015–2023 (USD MILLION) 81 

TABLE 77 ASIA-PACIFIC: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2015–2023 (USD MILLION) 82 

TABLE 78 JAPAN: CBD OIL MARKET, BY PRODUCT 2015–2023 (USD MILLION) 82 

TABLE 79 JAPAN: CBD OIL MARKET, BY APPLICATION 2015–2023 (USD MILLION) 83 

TABLE 80 JAPAN: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2015–2023 (USD MILLION) 83 

TABLE 81 CHINA: CBD OIL MARKET, BY PRODUCT 2015–2023 (USD MILLION) 84 

TABLE 82 CHINA: CBD OIL MARKET, BY APPLICATION 2015–2023 (USD MILLION) 84 

TABLE 83 CHINA: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2015–2023 (USD MILLION) 85 

TABLE 84 AUSTRALIA: CBD OIL MARKET, BY PRODUCT 2015–2023 (USD MILLION) 85 

TABLE 85 AUSTRALIA: CBD OIL MARKET, BY APPLICATION 2015–2023 (USD MILLION) 86 

TABLE 86 AUSTRALIA: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2015–2023 (USD MILLION) 86 

TABLE 87 INDIA: CBD OIL MARKET, BY PRODUCT 2015–2023 (USD MILLION) 87 

TABLE 88 INDIA: CBD OIL MARKET, BY APPLICATION 2015–2023 (USD MILLION) 87 

TABLE 89 INDIA: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2015–2023 (USD MILLION) 88 

TABLE 90 SOUTH KOREA: CBD OIL MARKET, BY PRODUCT 2015–2023 (USD MILLION) 89 

TABLE 91 SOUTH KOREA: CBD OIL MARKET, BY APPLICATION 2015–2023 (USD MILLION) 89 

TABLE 92 SOUTH KOREA: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2015–2023 (USD MILLION) 90 

TABLE 93 REST OF ASIA-PACIFIC: CBD OIL MARKET, BY PRODUCT 2015–2023 (USD MILLION) 90 

TABLE 94 REST OF ASIA-PACIFIC: CBD OIL MARKET, BY APPLICATION 2015–2023 (USD MILLION) 91 

TABLE 95 REST OF ASIA-PACIFIC: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2015–2023 (USD MILLION) 91 

TABLE 96 REST OF THE WORLD: CBD OIL MARKET, BY REGION 2015–2023 (USD MILLION) 92 

TABLE 97 REST OF THE WORLD: CBD OIL MARKET, BY PRODUCT 2015–2023 (USD MILLION) 92 

TABLE 98 REST OF THE WORLD: CBD OIL MARKET, BY APPLICATION 2015–2023 (USD MILLION) 93 

TABLE 99 REST OF THE WORLD: CBD OIL MARKET, BY DISTRIBUTION CHANNEL 2015–2023 (USD MILLION) 93 

FIGURE 1 GLOBAL CBD OIL MARKET: MARKET STRUCTURE 14 

FIGURE 2 RESEARCH PROCESS 16 

FIGURE 3 TOP-DOWN & BOTTOM-UP APPROACH 19 

FIGURE 4 MARKET DYNAMICS: ANALYSIS OF GLOBAL CBD OIL MARKET 21 

FIGURE 5 VALUE CHAIN: GLOBAL CBD OIL MARKET 26 

FIGURE 6 PORTER’S FIVE FORCES ANALYSIS: GLOBAL CBD OIL MARKET 27 

FIGURE 7 GLOBAL HEMP BASED PRODUCTS MARKET, BY INDUSTRIAL APPLICATION, 2017 (%) 31 

FIGURE 8 GLOBAL HEMP BASED PRODUCTS MARKET, BY HEMP CBD PRODUCT TYPE, 2017 (%) 31 

FIGURE 9 GLOBAL HEMP BASED PRODUCTS MARKET, BY REGION, 2017 & 2023 (USD MILLION) 32 

FIGURE 10 GLOBAL HEMP BASED PRODUCTS MARKET, BY INDUSTRIAL APPLICATION, 2017 & 2023 (USD MILLION) 36 

FIGURE 11 GLOBAL HEMP BASED PRODUCTS MARKET, FOR HEMP CBD BY TYPE, 2017 & 2023 (USD MILLION) 37 

FIGURE 12 GLOBAL HEMP BASED PRODUCTS MARKET, FOR HEMP CBD BY TYPE, 2017 & 2023 (VOLUME) 38 

FIGURE 13 GLOBAL CBD OIL MARKET, BY PRODUCT, 2017 & 2023 (USD MILLION) 41 

FIGURE 14 GLOBAL CBD OIL MARKET, BY APPLICATION, 2017 & 2023 (USD MILLION) 45 

FIGURE 15 GLOBAL CBD OIL MARKET, BY DISTRIBUTION CHANNEL, 2017 & 2023 (USD MILLION) 49 

FIGURE 16 GLOBAL CBD OIL MARKET, BY REGION 2017 & 2023 (USD MILLION) 54 

FIGURE 17 AMERICAS: CBD OIL MARKET SHARE, BY REGION 2017 55 

FIGURE 18 NORTH AMERICA: CBD OIL MARKET SHARE, BY COUNTRY 2017 57 

FIGURE 19 EUROPE: CBD OIL MARKET SHARE, BY REGION 2017 64 

FIGURE 20 WESTERN EUROPE: CBD OIL MARKET SHARE, BY COUNTRY 2017 66 

FIGURE 21 ASIA-PACIFIC: CBD OIL MARKET SHARE, BY COUNTRY 2017 80 

FIGURE 22 REST OF THE WORLD: CBD OIL MARKET SHARE, BY REGION 2017 92 

FIGURE 23 GLOBAL CBD OIL MARKET SHARE ANALYSIS, 2017 (%) 95 

Purchase this Market Research Report

REACH OUT TO US

Call us on : +1 888 709 8757

Drop us an email at : info@researchcosmos.com

HAVE A QUESTION?